Samples were analyzed for a variety of metabolic variables (e.g., glucose, HbA1c, lipid panel, C-reactive protein, nitrate/nitrite, and several markers of oxidative stress)
Li S, Li Q, Li Y, Li L, Tian H, Sun X
Most weight-related outcomes used ~12 g/day
In addition to their benefits for blood sugar and weight management, GLP-1 medications also contribute positively to cardiovascular health by improving lipid profiles and reducing blood pressure
This article delves into its mechanisms, clinical efficacy, dosing strategies, benefits, risks, and emerging research, providing a comprehensive overview of this innovative therapy
Primary candidates include patients with type 2 diabetes and established cardiovascular disease, those with multiple cardiovascular risk factors including dyslipidemia, and adults with obesity or overweight with weight-related comorbidities